Heidelberg Pharma Affirms FY26 Guidance

MT Newswires · 2d ago
01:23 AM EDT, 10/15/2026 (MT Newswires) -- Heidelberg Pharma (HPHA.F) maintained its guidance for fiscal 2026, according to a Thursday release. The German pharmaceutical company expects sales revenue and other income between 11 million euros and 15 million euros for the entirety of the fiscal year.